Encodes an F-box family protein involved in ubiquitin-mediated proteolysis, a key regulatory mechanism for protein turnover
Part of the SCF (SKP1-CUL1-F-box protein) E3 ubiquitin ligase complex that tags proteins for degradation
Functional Significance
F-box proteins like AT2G39415 help regulate:
While specific validation data for this antibody is not explicitly detailed in available sources, standard quality assurance measures for commercial antibodies typically include:
Batch-to-batch consistency checks
Application-specific performance verification (e.g., Western blot banding patterns matching predicted molecular weight)
The antibody enables:
Protein Localization Studies: Tracking cellular distribution of AT2G39415 through immunofluorescence
Expression Profiling: Quantifying protein levels under different growth conditions or genetic backgrounds
Interaction Analyses: Identifying binding partners via co-immunoprecipitation
Mutant Characterization: Verifying protein absence in gene knockout lines
At2g39415 is a gene located on chromosome 2 of Arabidopsis thaliana, encoding a protein identified by UniProt accession number Q3EBJ8. This gene is part of the extensive genomic framework of Arabidopsis, which serves as a model organism for plant molecular and genetic research. Understanding this gene's function contributes to broader knowledge of plant developmental processes and stress responses. When designing experiments with the corresponding antibody, it's essential to consider the protein's predicted structure, expression patterns, and functional domains to appropriately interpret results.
The At2g39415 Antibody (CSB-PA666902XA01DOA) is suitable for several experimental applications in plant molecular biology research. These typically include:
| Application | Recommended Dilution | Sample Types |
|---|---|---|
| Western Blotting | 1:500-1:2000 | Total protein extracts, subcellular fractions |
| Immunoprecipitation | 1:50-1:200 | Plant tissue lysates |
| Immunohistochemistry | 1:100-1:500 | Fixed plant tissue sections |
| ELISA | 1:1000-1:5000 | Purified protein or crude extracts |
| Immunofluorescence | 1:100-1:500 | Fixed plant cells/tissues |
Researchers should validate these applications with appropriate controls specific to their experimental design. The antibody is available in both concentrated (0.1ml) and standard (2ml) preparations to accommodate different experimental scales .
Proper sample preparation is crucial for successful At2g39415 antibody applications. For protein extraction:
Harvest fresh plant material (preferably young leaves or seedlings) and immediately flash-freeze in liquid nitrogen
Grind tissue to a fine powder while keeping frozen
Extract proteins using a buffer containing:
50mM Tris-HCl (pH 7.5)
150mM NaCl
1% Triton X-100
0.5% sodium deoxycholate
1mM EDTA
Protease inhibitor cocktail
Centrifuge at 14,000g for 15 minutes at 4°C
Collect supernatant and quantify protein concentration
For Western blotting, denature samples at 95°C for 5 minutes in SDS sample buffer
This methodology ensures protein integrity while minimizing degradation and maximizing antibody recognition potential.
Rigorous experimental design requires appropriate controls when working with antibodies. For At2g39415 Antibody research, include:
Positive control: Protein extract from wild-type Arabidopsis thaliana known to express the target protein
Negative control: Protein extract from At2g39415 knockout/knockdown lines
Secondary antibody control: Sample processed with secondary antibody only (no primary antibody)
Blocking peptide control: Pre-incubation of antibody with its immunizing peptide to verify specificity
Loading control: Probing for a housekeeping protein (e.g., actin, tubulin) to verify equal loading
These controls help distinguish specific from non-specific signals and validate experimental results, addressing a common concern in antibody research regarding specificity.
Antibody specificity is paramount for reliable research outcomes. To validate the At2g39415 Antibody:
Perform Western blot analysis comparing wild-type and At2g39415 mutant plants
Conduct immunoprecipitation followed by mass spectrometry analysis to identify all proteins captured by the antibody
Test cross-reactivity with recombinant proteins of similar structure
Compare staining patterns in immunohistochemistry with known expression patterns from promoter-reporter studies
Evaluate antibody specificity across different Arabidopsis ecotypes
This comprehensive validation approach addresses concerns about non-specific binding, which is a documented issue with some commercially available antibodies as seen with AT2 receptor antibodies in other research contexts .
To preserve At2g39415 Antibody functionality:
| Parameter | Recommended Condition |
|---|---|
| Long-term storage | -20°C (avoid repeated freeze-thaw cycles) |
| Working aliquots | 4°C for up to 2 weeks |
| Buffer composition | PBS with 50% glycerol and 0.02% sodium azide |
| Stability enhancers | 0.5-1% BSA or 5% glycerol for diluted solutions |
| Light exposure | Minimize (particularly important for fluorophore-conjugated versions) |
| Contaminant avoidance | Use sterile technique when handling |
Improper storage can lead to reduced binding efficiency, increased background, and experimental variability. Document all freeze-thaw cycles and observe for any changes in performance over time.
For optimal Western blot results with the At2g39415 Antibody:
Perform a dilution series experiment (typically 1:500, 1:1000, 1:2000, 1:5000)
Load consistent protein amounts (20-50μg) across wells
Transfer proteins to membrane using standard protocols (PVDF often provides better results than nitrocellulose for plant proteins)
Block with 5% non-fat dry milk or 3% BSA in TBST for 1 hour at room temperature
Incubate with primary antibody dilutions overnight at 4°C
Wash thoroughly with TBST (3-5 times, 5 minutes each)
Incubate with HRP-conjugated secondary antibody (1:5000-1:10000) for 1 hour at room temperature
Develop using chemiluminescence and determine optimal dilution based on signal-to-noise ratio
This titration approach helps identify the concentration that provides maximum specific signal with minimal background.
Co-immunoprecipitation (Co-IP) with the At2g39415 Antibody enables identification of protein interaction networks:
Prepare plant lysates under non-denaturing conditions using a gentle lysis buffer:
50mM Tris-HCl (pH 7.5)
150mM NaCl
0.5% NP-40
1mM EDTA
Protease and phosphatase inhibitors
Pre-clear lysate with Protein A/G beads for 1 hour at 4°C
Incubate pre-cleared lysate with At2g39415 Antibody (2-5μg per mg of protein) overnight at 4°C
Add fresh Protein A/G beads and incubate for 2-4 hours at 4°C
Wash beads 5 times with wash buffer (lysis buffer with reduced detergent)
Elute proteins by boiling in SDS sample buffer
Analyze by SDS-PAGE followed by:
Western blotting for suspected interaction partners
Silver staining and mass spectrometry for unbiased partner identification
This approach can reveal physiologically relevant protein complexes and regulatory mechanisms involving the At2g39415 gene product.
Post-translational modifications (PTMs) can interfere with antibody recognition. When working with the At2g39415 Antibody:
Phosphorylation interference: Treat samples with lambda phosphatase to remove phosphate groups that might mask epitopes
Glycosylation masking: Use PNGase F or Endo H treatment to remove N-linked glycans
Conformational epitope access: Optimize denaturation conditions or test native vs. denatured detection
Multiple antibody approach: Use antibodies recognizing different epitopes of the same protein
PTM-specific antibodies: Consider using antibodies specifically designed to recognize modified forms
These strategies help ensure comprehensive detection of the target protein regardless of its modification state, providing insights into the protein's regulatory mechanisms.
For researchers investigating DNA-protein interactions involving the At2g39415 gene product:
Crosslink plant tissue with 1% formaldehyde for 10-15 minutes under vacuum
Quench with 125mM glycine for 5 minutes
Extract and sonicate chromatin to fragments of 200-500bp
Pre-clear chromatin with Protein A/G beads
Incubate pre-cleared chromatin with At2g39415 Antibody (5-10μg) overnight at 4°C
Add fresh Protein A/G beads and incubate for 2-4 hours
Perform sequential washes with increasing stringency buffers
Reverse crosslinks by heating at 65°C overnight
Purify DNA and analyze by qPCR or sequencing
ChIP experiments can reveal genomic binding sites and regulatory functions of the At2g39415 protein if it participates in transcriptional regulation or chromatin remodeling.
| Issue | Potential Causes | Solutions |
|---|---|---|
| False positives | Non-specific binding | Increase blocking time/concentration; optimize antibody dilution |
| Cross-reactivity with similar proteins | Pre-absorb antibody; use knockout controls | |
| Secondary antibody issues | Include secondary-only controls | |
| False negatives | Epitope destruction during sample preparation | Optimize extraction conditions; try different lysis buffers |
| Low target protein expression | Increase sample concentration; use sensitive detection methods | |
| Incorrect subcellular fractionation | Validate fractionation with marker proteins | |
| Improper antibody storage | Use fresh aliquots; verify antibody activity |
This systematic approach to troubleshooting helps researchers distinguish between technical issues and genuine biological phenomena. Similar methodology has been employed with antibodies in SARS-CoV-2 research, where specificity is critical .
When facing discrepancies between antibody-based detection and other methods:
Verify antibody specificity through knockout/knockdown validation
Consider the epitope location and whether it might be masked in certain contexts
Evaluate protein expression levels through orthogonal methods:
qRT-PCR for mRNA expression
Reporter gene fusions for protein localization
Mass spectrometry for protein identification and quantification
Assess if detection thresholds differ between methods
Consider if post-translational modifications affect detection
Evaluate if protein-protein interactions obscure epitope accessibility
Method triangulation increases confidence in results and helps identify technique-specific limitations. Recent studies with therapeutic antibodies demonstrate the importance of using multiple validation approaches .
Batch variation is a significant concern in antibody research. To monitor and address this issue:
Maintain a reference sample set tested with the original antibody batch
Run side-by-side comparisons with old and new antibody batches
Document key performance metrics:
Signal-to-noise ratio
Detection threshold
Banding pattern in Western blots
Localization pattern in immunostaining
Request lot-specific validation data from suppliers
Consider preparing a large single batch of antibody for long-term projects
Implement a standard curve with recombinant protein to normalize across experiments
This approach aligns with best practices observed in biomedical research, where antibody reliability issues have been documented and require systematic assessment .
To study At2g39415 protein dynamics during stress:
Design time-course experiments exposing plants to relevant stressors (drought, salt, pathogen, temperature)
Collect tissue samples at defined intervals (0, 1, 3, 6, 12, 24, 48 hours)
Process parallel samples for:
Protein extraction and Western blotting with At2g39415 Antibody
RNA extraction and qRT-PCR for transcript analysis
Immunolocalization to track protein redistribution
Quantify protein levels through densitometry
Correlate protein abundance with transcriptional changes
Track post-translational modifications using phospho-specific antibodies if available
Perform co-immunoprecipitation at key timepoints to identify stress-specific interaction partners
This comprehensive approach provides insights into protein regulation mechanisms during stress adaptation.
For super-resolution microscopy applications:
Sample preparation optimization:
Use thin tissue sections (≤10μm) or isolated cells
Optimize fixation protocols to preserve antigenicity while maintaining structure
Evaluate alternative fixation methods (paraformaldehyde vs. methanol vs. glutaraldehyde)
Antibody considerations:
Use highly purified antibody preparations
Consider directly conjugated primary antibodies to improve localization precision
Validate specificity at the subcellular level using knockout controls
Test different antibody concentrations to maximize signal while minimizing background
Imaging parameters:
Select appropriate fluorophores with photostability suitable for super-resolution
Optimize imaging buffers to enhance fluorophore performance
Include fiducial markers for drift correction
Perform multicolor imaging with carefully selected non-overlapping fluorophores
Data analysis:
Apply appropriate image processing algorithms
Quantify colocalization with subcellular markers
Perform statistical analysis of spatial distribution
These considerations ensure reliable protein localization at nanoscale resolution, providing insights into protein function within cellular compartments.
Integrating antibody detection with CRISPR-Cas9 technology:
Design and generate CRISPR-Cas9 edited Arabidopsis lines:
Complete gene knockout
Domain-specific mutations
Epitope-tagged versions (ensuring tags don't interfere with antibody binding)
Validation experiments:
Confirm editing through sequencing
Verify protein reduction/modification by Western blotting with At2g39415 Antibody
Assess subcellular localization changes via immunofluorescence
Quantify protein-protein interaction alterations through co-immunoprecipitation
Phenotypic analysis:
Document morphological changes
Measure physiological parameters
Assess stress responses
Analyze developmental timing
Rescue experiments:
Complement edited lines with wild-type or modified gene versions
Verify protein expression using the At2g39415 Antibody
Correlate protein levels with phenotypic rescue
This combined approach provides robust evidence for gene function and protein activity, similar to validation strategies used in therapeutic antibody research .
Several cutting-edge technologies hold promise for expanding At2g39415 Antibody applications:
Proximity labeling: Conjugating biotin ligases (BioID, TurboID) to antibodies for identifying transient or weak interaction partners
Single-cell proteomics: Combining the antibody with microfluidics and mass cytometry for cell-specific protein quantification
Intrabodies: Developing cell-permeable versions for live-cell imaging and protein manipulation
Nanobodies: Engineering smaller antibody fragments for improved tissue penetration and reduced immunogenicity
Biolayer interferometry: Using antibodies in label-free, real-time binding assays
Spatial transcriptomics integration: Combining immunolocalization with spatial gene expression analysis
Cryo-electron tomography: Using gold-conjugated antibodies for 3D ultrastructural localization
These technologies may overcome current limitations in detecting low-abundance proteins, resolving temporal dynamics, and identifying cell-type-specific functions of the At2g39415 gene product.
Computational methods enhance antibody research through:
Epitope prediction algorithms: Identifying optimal antibody binding sites
Molecular dynamics simulations: Predicting antibody-antigen interactions and conformational changes
Machine learning for image analysis: Automating protein localization and quantification in microscopy data
Network analysis tools: Interpreting protein-protein interaction data from co-immunoprecipitation
Integrative multi-omics analysis: Correlating antibody-based proteomics with transcriptomics and metabolomics
Phylogenetic analysis: Predicting cross-reactivity with related proteins across species
Quantitative image analysis: Extracting numerical data from immunohistochemistry for statistical comparison
These computational approaches transform qualitative antibody data into quantitative insights while improving experimental design and interpretation.